O2W is the next generation of Lipid-Based Drug Delivery Systems (LBDDSs) that was engineered to significantly enhance the solubility, bioavailability, potency, stability and time of onset of fat-soluble compounds, including cannabinoids.
It is the art of transforming Oil-soluble compounds into Water-soluble compounds.
Free of Polyethylene Glycols (PEGs) and medium and short-chain alcohols, O2W is the only self-dispersing and fully water-dilutable Self-Microemulsifying Drug Delivery System (SMEDDS) made with food-grade excipients.
Unlike first generation PEG-based formulations, O2W does not compromise on:
Performance, Safety or Sustainability.
Water-free Concentrate
Formulation Platform
High-potency, fast-acting
(immediate-release)
Microencapsulated Powder
Formulation Platform
Extra high-potency,
tunable-release
Semi-solid FormulationPlatform
High-potency, extended-release
Our breakthrough, proprietary product platforms can be customized to produce an unmatched variety of dosage forms with tunable release profiles.
Create the most unique and innovative products on the market, while providing your consumers with the best experience.
According to Micellae’s pharmacokinetic (PK) study, O2W has an unprecedented onset of action, with the maximum concentration of CBD achieved at 20-30 min compared to unformulated CBD at 4-6 hours. This means your consumer will feel the effects in minutes, not hours.
O2W also demonstrated a substantial improvement of CBD bioavailability through a significant increase in area under curve (AUC) and Cmax, compared to control group.
O2W self-microemulsification under an electronic microscope.
Our experts will work with you every step of the way to find the best solution for your product.
Integrating O2W into your manufacturing process and products is seamless and inexpensive.
Micellae is an innovative technology-based company founded on 15 years of research and engineering at University of Toronto.
We aim to provide the most advanced Drug Delivery System to high-quality pharmaceutical, medical and recreational cannabis producers.
Our in-house scientific experts, led by CEO and founder, Dr. Mehdi Nouraei, are deeply knowledgeable about Drug Delivery Systems.
We’re further strengthened by an executive and advisory team with in-depth expertise and experience in the pharmaceutical and health care industries.
100 College St, Suite 150
Toronto, ON M5G 1L5
CANADA
Tel: (416) 556-2437
E-mail: Info@micellae.com
Copyright © 2023 MICELLAE Delivery Systems Inc. All rights reserved.